The Texas Heart Institute Welcomes Interventional Cardiologist and Heart Failure Specialist Dr. Nikolaos Diakos
HOUSTON (September 22, 2022) — Nikolaos A. Diakos, MD, PhD, an interventional cardiologist and specialist in heart failure, has joined the Texas Heart Medical Group and will also collaborate with The Texas Heart Institute’s research community to pioneer new treatments and devices.
“Dr. Diakos strengthens our longstanding commitment to clinical excellence in the modern diagnosis and management of heart failure and the use of the most contemporary and innovative tools to treat patients with coronary artery disease,” said Dr. Eduardo Hernandez, President of the medical group.
Dr. Diakos comes to Houston from Montefiore Medical Center, Bronx, New York. He received his medical and doctoral degrees from the University of Athens.
After graduation, Dr. Diakos moved to the United States to complete a fellowship in translational research at the joint Utah Cardiac Recovery Program/University of Utah Molecular Medicine Program/Eccles Institute of Human Genetics in Salt Lake City, Utah. He then pursued a residency in internal medicine at the University of Utah. Following that, Dr. Diakos completed a clinical and research fellowship in cardiovascular disease at Tufts Medical Center in Boston, a fellowship in advanced heart failure and transplantation at New York Presbyterian Hospital-Columbia University in New York City, and interventional cardiology training at Montefiore in New York.
He is recognized for his substantial clinical and translational research accomplishments in the areas of heart failure and mechanical cardiac support. He has authored many papers in high-impact, peer-reviewed journals such as the Journal of the American College of Cardiology and the Journal of Heart and Lung Transplantation. He has also won almost a dozen awards for his research, including an award from the International Society for Heart and Lung Transplantation, a Research Merit Scholarship from the Acute Cardiac Unloading and Recovery Working Group (A-Cure), and numerous awards from the Hellenic Cardiological Society.
“Dr. Diakos has remarkable clinical and research expertise that aligns with our mission and vision of delivering the highest quality care and maintaining a culture of innovation, discovery, and excellence in patient care,” added Dr. Joseph G. Rogers, President, and CEO of the Texas Heart Institute.
Dr. Diakos is certified by the Educational Commission for Foreign Medical Graduates, the American Board of Internal Medicine (Internal Medicine, Cardiovascular Disease), and the National Board of Echocardiography. He will see patients at The Texas Heart Institute Medical Group at 6624 Fannin Suite 2780, Houston, Texas 77030. For appointments, call (713) 790-9401.
# # #
ABOUT TEXAS HEART MEDICAL GROUP
Texas Heart Medical Group is a multicultural clinical practice specializing in comprehensive cardiovascular care with a mission to promote wellness and longevity while providing the highest-quality medical care in a sophisticated and welcoming patient-oriented atmosphere. Texas Heart Medical Group physicians are internationally known for their expertise in the diagnosis, treatment, and prevention of cardiovascular diseases and practice patient-centered care utilizing state-of-the-art approaches, including non-invasive and invasive procedures. http://www.texasheartmedical.org/
ABOUT TEXAS HEART INSTITUTE
Texas Heart Institute, founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to reducing the devastating toll of cardiovascular disease through innovative and progressive programs in research, education, and improved patient care. Participating in research programs in cardiology, cardiovascular surgery, stem cell, gene therapy, and regenerative medicine research programs, the institute’s scientists and physicians spearhead some of the most innovative medical research in the medical field. Texas Heart Institute continues to uncover underlying causes of heart disease and the ways to better treat and even prevent it through translational, basic, and clinical research programs. With initiatives ranging from postdoctoral and continued medical education to public outreach and scientific publications, Texas Heart Institute is dedicated to spreading awareness and sharing updates on ways to prevent, treat, and defeat cardiovascular disease. As a global leader in cardiac patient care, Texas Heart Institute has been ranked among the top cardiovascular centers in the United States by U.S. News & World Report for over 30 years. www.texasheart.org